Life Sciences & Healthcare
Kempen Life Sciences & Healthcare is uniquely positioned as a dedicated specialist adviser in the life sciences & healthcare sector. Over recent years, we have built a strong position and extensive track-record in European IPOs and other capital market transactions and have emerged as a trusted adviser in various cross-border mergers & acquisitions and other advisory services. We combine our in-depth knowledge of the financial sector with a scientific background and extensive industry experience.
PROVEN GLOBAL TRACK RECORD
The continuous search for new treatments makes life sciences & healthcare a dynamic and ever evolving market. Our dedicated Life Sciences & Healthcare team is the largest of its kind in Europe and is widely renowned for independent advice and a proven track record. The team has successfully executed over 100 life sciences transactions since its inception in 2005. We provide access to a global network of specialist and generalist investors with a significant US footprint and have longstanding experience with both listed and private companies across the world. This enables us to use market insights to provide our clients with invaluable support. Together with our specialised equity research, sales and trading teams, we provide global visibility to selected European life sciences & healthcare companies through active research, regular sector outlooks, road shows, proactive block trading and our annual investor conference.
Life Sciences & Healthcare Newsletters
Coming up Hot in Healthcare 2019
Life Sciences Investor Survey 2019
Transactions
No transactions found
Secondary placing of Fagron shares
Rights issue
a subsidiary of
Sale of German DIY portfolio to REDOS acting on behalf of Union Investment
Accelerated bookbuild offering
Accelerated Bookbuild Offering on behalf of selling shareholders in
Three-day bookbuild offering
Rights issue
Initial Public Offering
Accelerated Bookbuild Offering
Block trade in argenx shares
a subsidiary of
Sale of German retail portfolio to a real estate private equity firm
Sale of Dutch residential portfolio managed by
on behalf of investors to
Sale of
to
Bencis Capital Partners
Initial Public Offering
Capital increase
Block trade in ERYTECH shares
Initial public offering
Accelerated bookbuild offering
Initial public offering
Acquisition of
US public offering
US public offering
US public offering
Sale to
Block trade in Boskalis shares
Sale of Rabo Bouwfonds CIF datacenter portfolio
to
Initial public offering
Acquisition of former Delta Lloyd portfolio from
Rights issue
Accelerated bookbuild offering
Public offer for
Fundraise
Public offer by German ADLER Real Estate
for Israeli
Sale of Dynamic Portfolios
Accelerated bookbuild offering
Public offer by German Vonovia
Accelerated bookbuild offering
Public offer by Spanish Colonial
for Spanish Axiare Real Estate
Sale of 3 German residential portfolios by Angelo Gordon
to consortium of buyers
US public offering
Accelerated bookbuild offering
Secondary offering
Accelerated bookbuild offering
Accelerated bookbuild offering
Acquisition by
of
Acquisition of
by
Private placement
Acquisition by
of
Dutch wealth management activities
Acquisition by
of
from
Accelerated bookbuild offering
Initial public offering on NASDAQ
Share buy-back program
Acquisition by
of
Accelerated bookbuild offering
Secondary placement of 9.4% stake in
Public offer by
for
Public offer by German Vonovia
For Austrian Conwert
Secondary placement of 15% stake in
Formation of Passoã joint venture with
Accelerated bookbuild offering
Rights issue
Sale of 19% stake in
Accelerated bookbuild offering
Acquisition of the North American rights to RUCONEST by
from
Acquisition by
of
from
Strategic study
Secondary placement 30% stake in
Share buy-back program
Direct share placement
Private placement
Strategic study
Sale of the European veterinary business of
to
Strategic study
Private placement
Placement of treasury shares
Public offer for Deutsche Office
By German Alstria
Public offer for
Initial public offering
Rights issue
Rights issue
Initial public offering
Rights issue
Sale of
to
Residential portfolio sale by Dekor
A company owned by Reggeborgh
Rights issue
Accelerated bookbuild offering
Secondary placement of 35% stake in IOW
Accelerated bookbuild offering
Refinancing
Rights issue
Refinancing
Capital Raise
Initial public offering
Acquisition by
of
Refinancing
Initial Public Offering
Initial public offering
Rights issue
On behalf of
Acquisition of
Rights issue
Acquisition of French shopping centre portfolio by Wereldhave
From French-Dutch Unibail-Rodamco
Refinancing
Acquisition of the cancer immunotherapy program by
from
Initial public offering
Initial public offering
Public offer by French Groupe SMABTP
For French Société de la Tour Eiffel
Acquisition of
by
Secondary listing on Euronext Paris
Initial public offering
Acquisition by
of
Accelerated bookbuild offering
Convertible bond issue
Fairness opinion in the public offer by
Sale of Hercules business to ZEG
Refinancing
Convertible bond issue
Initial public offering
Sale of Dutch supply assets to
Accelerated bookbuild, preference shares issue and refinancing
Acquisition of
by
undisclosed PE firm
from
At-market rights issue
Acquisition by
of
Accelerated bookbuild offering
Private placement by acquisition vehicle for French Carrefour
Secondary offering
Combined offering of primary and secondary shares
Public offer for German listed GSW
by German listed
Initial Public Offering
Equity issue
Refinancing
Sale of majority of shares to
Accelerated bookbuild offering
Initial public offering
Secondary offering
Accelerated bookbuild offering
Public offer by
for
Private placement
Public offer by
for
Rights issue
Contact
Want to know more?
Leave your company email address and we will contact you
